[Treatment of chronic schizophrenics with reduced drive with Aponeuron].
D000293:Adolescent; D000328:Adult; D000342:Affective Symptoms / Q000188:drug therapy; D000374:Aggression / Q000187:drug effects; D000553:Ambulatory Care; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D004328:Drive / Q000187:drug effects*; D004341:Drug Evaluation; D004644:Emotions / Q000187:drug effects; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D009570:Nitriles / Q000008:administration & dosage / Q000627:therapeutic use*; D011437:Propylamines / Q000008:administration & dosage / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D000928:Antidepressive Agents; D009570:Nitriles; D011437:Propylamines
Uber die Behandlung von antriebsgeminderten chronischen Schizophrenien mit Aponeuron.